Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Teclison Ltd.
Teclison Ltd.
Eli Lilly and Company
Fundación de investigación HM
National Health Research Institutes, Taiwan
Molecular Partners AG
National Institutes of Health Clinical Center (CC)
Turning Point Therapeutics, Inc.
Melanoma and Skin Cancer Trials Limited
Hoffmann-La Roche
National Institutes of Health Clinical Center (CC)
Crinetics Pharmaceuticals Inc.
Assiut University
M.D. Anderson Cancer Center
Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
University of Florida
YourChoice Therapeutics, Inc.
Enterome
Chimeric Therapeutics
IDEAYA Biosciences
Eli Lilly and Company
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Tanabe Pharma America, Inc.
Perspective Therapeutics
Colorado State University
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
BioXcel Therapeutics Inc
Phanes Therapeutics
Vyriad, Inc.
Hutchmed
National Health Research Institutes, Taiwan
PharmaMar
Cancer Research UK
Hoffmann-La Roche
University Hospital, Basel, Switzerland
AHS Cancer Control Alberta
Hutchmed
Imperial College London
National Institutes of Health Clinical Center (CC)
Crinetics Pharmaceuticals Inc.
Peking Union Medical College Hospital
Memorial Sloan Kettering Cancer Center
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Purple Biotech Ltd.
Aminex Therapeutics, Inc.
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Uppsala University
23andMe, Inc.
Cancer Institute and Hospital, Chinese Academy of Medical Sciences